Click here to view online. Add this email to your safelist.

AstraZeneca logo

Matching drug and disease omic signatures for drug repurposing

15 February 2023

The pace of change in healthcare is moving more rapidly than ever before. To maximise the delivery of potential new medicines, we are using data driven methods to associate existing medicines with new disease indications with the aim to make drug discovery faster and more efficient. These data driven methods allow us to apply existing chemistry to new disease areas, maximising benefits for patients. 

Read more  Read more

RSS Feed  RSS Feed Twitter  Follow us on Twitter LinkedIn  Follow us on LinkedIn
Legal notice and Terms of Use Privacy policy Cookie policy Site map © AstraZeneca 2023

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.